Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.
暂无分享,去创建一个
L. Leibovici | C. Acosta | E. Goldberg | A. Fraser | M. Paul
[1] Z. Bhutta. Current concepts in the diagnosis and treatment of typhoid fever , 2006, BMJ : British Medical Journal.
[2] Nguyen Dinh Son,et al. The feasibility of a school-based VI polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy. , 2006, The Southeast Asian journal of tropical medicine and public health.
[3] C. Acosta,et al. Efficacy of a locally produced, Chinese Vi polysaccharide typhoid fever vaccine during six years of follow-up. , 2005, Vaccine.
[4] A. Donner,et al. A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial , 2005, BMC public health.
[5] J. Crump,et al. The global burden of typhoid fever. , 2004, Bulletin of the World Health Organization.
[6] S. Szu,et al. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. , 2003, The New England journal of medicine.
[7] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[8] K. Brown,et al. Salmonella vaccines for use in humans: present and future perspectives. , 2002, FEMS microbiology reviews.
[9] R. Black,et al. Typhoid fever in Bangladesh: implications for vaccination policy. , 2001, The Pediatric infectious disease journal.
[10] J. Shiloach,et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. , 2001, The New England journal of medicine.
[11] S. Zhang,et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. , 2001, Bulletin of the World Health Organization.
[12] J. Lau,et al. Vaccines for preventing typhoid fever , 2018, The Cochrane database of systematic reviews.
[13] M. Levine,et al. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. , 1999, Vaccine.
[14] B. Singh,et al. Typhoid fever in children aged less than 5 years , 1999, The Lancet.
[15] M. Falagas,et al. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity , 1998, BMJ.
[16] J. Shi,et al. [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine]. , 1997, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[17] J. Robbins,et al. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. , 1996, Vaccine.
[18] M. Bennish. Immunization Against Salmonella typhi , 1995 .
[19] W. Keitel,et al. Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. , 1994, Vaccine.
[20] M. Levine,et al. Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children. , 1992, The Journal of infectious diseases.
[21] S. Hoffman,et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine , 1991, The Lancet.
[22] M. Levine,et al. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial , 1990, The Lancet.
[23] M. Levine,et al. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. , 1990, Vaccine.
[24] M. Levine,et al. Typhoid vaccines come of age , 1989, The Pediatric infectious disease journal.
[25] M. Levine,et al. The current status of typhoid vaccine development and clinical trials with typhoid vaccines. , 1988, Southeast Asian Journal of Tropical Medicine and Public Health.
[26] R. Schneerson,et al. PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER , 1987, The Lancet.
[27] R. Thapa,et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. , 1987, The New England journal of medicine.
[28] R. Black,et al. LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION , 1987, The Lancet.
[29] M. Levine,et al. Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules. , 1983, Developments in biological standardization.
[30] C. Serié,et al. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. , 1982, The Journal of infectious diseases.
[31] C. Serié,et al. A controlled field trial of liver oral typhoid vaccine Ty21a. , 1980, Bulletin of the World Health Organization.